These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 32824625)

  • 1. Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview.
    Vismara M; Girone N; Cirnigliaro G; Fasciana F; Vanzetto S; Ferrara L; Priori A; D'Addario C; Viganò C; Dell'Osso B
    Brain Sci; 2020 Aug; 10(8):. PubMed ID: 32824625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers of generalized anxiety disorder.
    Maron E; Nutt D
    Dialogues Clin Neurosci; 2017 Jun; 19(2):147-158. PubMed ID: 28867939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety disorders: clinical presentation and epidemiology.
    Lieb R
    Handb Exp Pharmacol; 2005; (169):405-32. PubMed ID: 16594266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and Clinical Markers to Differentiate the Type of Anxiety Disorders.
    Cosci F; Mansueto G
    Adv Exp Med Biol; 2020; 1191():197-218. PubMed ID: 32002931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICD-11 and DSM-5 personality trait domains capture categorical personality disorders: Finding a common ground.
    Bach B; Sellbom M; Skjernov M; Simonsen E
    Aust N Z J Psychiatry; 2018 May; 52(5):425-434. PubMed ID: 28835108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Under-recognition and under-treatment of DSM-IV classified mood and anxiety disorders among disability claimants.
    Cornelius B; van der Klink JJ; Brouwer S; Groothoff JW
    Disabil Rehabil; 2014; 36(14):1161-8. PubMed ID: 24024541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speculations on the Future of Psychiatric Diagnosis.
    Rush AJ; Ibrahim HM
    J Nerv Ment Dis; 2018 Jun; 206(6):481-487. PubMed ID: 29781887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human brain evolution and the "Neuroevolutionary Time-depth Principle:" Implications for the Reclassification of fear-circuitry-related traits in DSM-V and for studying resilience to warzone-related posttraumatic stress disorder.
    Bracha HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):827-53. PubMed ID: 16563589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sea piracy sequelae: assessment according to the Diagnostic and Statistical Manual of Mental Disorders-5.
    Ziello AR; Fasanaro AM; Petrelli C; Ricci G; Sirignano A; Amenta F
    Int Marit Health; 2014; 65(4):230-4. PubMed ID: 25522708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine in Alzheimer's disease and depression.
    Souslova T; Marple TC; Spiekerman AM; Mohammad AA
    Contemp Clin Trials; 2013 Nov; 36(2):616-23. PubMed ID: 23816492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSM-IV and DSM-5 social anxiety disorder in the Australian community.
    Crome E; Grove R; Baillie AJ; Sunderland M; Teesson M; Slade T
    Aust N Z J Psychiatry; 2015 Mar; 49(3):227-35. PubMed ID: 25122449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Markers in Anxiety Disorders.
    Łoś K; Waszkiewicz N
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on psychiatric disorders and defensive process assessed by the "defense style questionnaire" in sterile males SAMPLE consulting in andrology].
    Bellone M; Cottencin O; Rigot JM; Goudemand M
    Encephale; 2005; 31(4 Pt 1):414-25. PubMed ID: 16389709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical epidemiology in patients admitted at Mathari Psychiatric Hospital, Nairobi, Kenya.
    Ndetei DM; Khasakhala L; Maru H; Pizzo M; Mutiso V; Ongecha-Owuor FA; Kokonya DA
    Soc Psychiatry Psychiatr Epidemiol; 2008 Sep; 43(9):736-42. PubMed ID: 18465102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current diagnosis and treatment of anxiety disorders.
    Bystritsky A; Khalsa SS; Cameron ME; Schiffman J
    P T; 2013 Jan; 38(1):30-57. PubMed ID: 23599668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging and Genetic Approaches to Inform Biomarkers for Anxiety Disorders, Obsessive-Compulsive Disorders, and PSTD.
    Maron E; Lan CC; Nutt D
    Curr Top Behav Neurosci; 2018; 40():219-292. PubMed ID: 29796838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anxiety disorders in DSM-5: an overview on changes in structure and content].
    Wittchen HU; Heinig I; Beesdo-Baum K
    Nervenarzt; 2014 May; 85(5):548-52. PubMed ID: 24737036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.